BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

693 related articles for article (PubMed ID: 15163728)

  • 1. Circulating anti-wild-type adeno-associated virus type 2 (AAV2) antibodies inhibit recombinant AAV2 (rAAV2)-mediated, but not rAAV5-mediated, gene transfer in the brain.
    Peden CS; Burger C; Muzyczka N; Mandel RJ
    J Virol; 2004 Jun; 78(12):6344-59. PubMed ID: 15163728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Striatal readministration of rAAV vectors reveals an immune response against AAV2 capsids that can be circumvented.
    Peden CS; Manfredsson FP; Reimsnider SK; Poirier AE; Burger C; Muzyczka N; Mandel RJ
    Mol Ther; 2009 Mar; 17(3):524-37. PubMed ID: 19142181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-existing immunity to adeno-associated virus (AAV)2 limits transgene expression following intracerebral AAV2-based gene delivery in a 6-hydroxydopamine model of Parkinson's disease.
    Janelidze S; Nordström U; Kügler S; Brundin P
    J Gene Med; 2014; 16(9-10):300-8. PubMed ID: 25303717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice.
    Rivière C; Danos O; Douar AM
    Gene Ther; 2006 Sep; 13(17):1300-8. PubMed ID: 16688207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential.
    Li Q; Miller R; Han PY; Pang J; Dinculescu A; Chiodo V; Hauswirth WW
    Mol Vis; 2008 Sep; 14():1760-9. PubMed ID: 18836574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated delivery of adeno-associated virus vectors to the rabbit airway.
    Beck SE; Jones LA; Chesnut K; Walsh SM; Reynolds TC; Carter BJ; Askin FB; Flotte TR; Guggino WB
    J Virol; 1999 Nov; 73(11):9446-55. PubMed ID: 10516053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant AAV serotype 1 transduction efficiency and tropism in the murine brain.
    Wang C; Wang CM; Clark KR; Sferra TJ
    Gene Ther; 2003 Aug; 10(17):1528-34. PubMed ID: 12900769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled delivery of glial cell line-derived neurotrophic factor by a single tetracycline-inducible AAV vector.
    Chtarto A; Yang X; Bockstael O; Melas C; Blum D; Lehtonen E; Abeloos L; Jaspar JM; Levivier M; Brotchi J; Velu T; Tenenbaum L
    Exp Neurol; 2007 Mar; 204(1):387-99. PubMed ID: 17223106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adeno-associated viral vector serotypes 1 and 5 targeted to the neonatal rat and pig striatum induce widespread transgene expression in the forebrain.
    Kornum BR; Stott SR; Mattsson B; Wisman L; Ettrup A; Hermening S; Knudsen GM; Kirik D
    Exp Neurol; 2010 Mar; 222(1):70-85. PubMed ID: 20025873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological aspects of recombinant adeno-associated virus delivery to the mammalian brain.
    Mastakov MY; Baer K; Symes CW; Leichtlein CB; Kotin RM; During MJ
    J Virol; 2002 Aug; 76(16):8446-54. PubMed ID: 12134047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system.
    Burger C; Gorbatyuk OS; Velardo MJ; Peden CS; Williams P; Zolotukhin S; Reier PJ; Mandel RJ; Muzyczka N
    Mol Ther; 2004 Aug; 10(2):302-17. PubMed ID: 15294177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced transduction of mouse salivary glands with AAV5-based vectors.
    Katano H; Kok MR; Cotrim AP; Yamano S; Schmidt M; Afione S; Baum BJ; Chiorini JA
    Gene Ther; 2006 Apr; 13(7):594-601. PubMed ID: 16341060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adeno-associated virus antibody profiles in newborns, children, and adolescents.
    Calcedo R; Morizono H; Wang L; McCarter R; He J; Jones D; Batshaw ML; Wilson JM
    Clin Vaccine Immunol; 2011 Sep; 18(9):1586-8. PubMed ID: 21775517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralizing antibodies against adeno-associated virus examined prospectively in pediatric patients with hemophilia.
    Li C; Narkbunnam N; Samulski RJ; Asokan A; Hu G; Jacobson LJ; Manco-Johnson MJ; Monahan PE;
    Gene Ther; 2012 Mar; 19(3):288-94. PubMed ID: 21697954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transduction profiles of recombinant adeno-associated virus vectors derived from serotypes 2 and 5 in the nigrostriatal system of rats.
    Paterna JC; Feldon J; Büeler H
    J Virol; 2004 Jul; 78(13):6808-17. PubMed ID: 15194756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time course of transgene expression after intrastriatal pseudotyped rAAV2/1, rAAV2/2, rAAV2/5, and rAAV2/8 transduction in the rat.
    Reimsnider S; Manfredsson FP; Muzyczka N; Mandel RJ
    Mol Ther; 2007 Aug; 15(8):1504-11. PubMed ID: 17565350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential Adeno-Associated Viral Vector Serotype 9-Green Fluorescent Protein Gene Transfer Causes Massive Inflammation and Intense Immune Response in Rat Striatum.
    Yang C; Hao F; He J; Lu T; Klein RL; Zhao LR; Duan WM
    Hum Gene Ther; 2016 Jul; 27(7):528-43. PubMed ID: 26847924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands.
    Aldrich WA; Ren C; White AF; Zhou SZ; Kumar S; Jenkins CB; Shaw DR; Strong TV; Triozzi PL; Ponnazhagan S
    Gene Ther; 2006 Jan; 13(1):29-39. PubMed ID: 16136165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient immunosuppression allows transgene expression following readministration of adeno-associated viral vectors.
    Manning WC; Zhou S; Bland MP; Escobedo JA; Dwarki V
    Hum Gene Ther; 1998 Mar; 9(4):477-85. PubMed ID: 9525309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focused ultrasound as a novel strategy for noninvasive gene delivery to retinal Müller glia.
    Touahri Y; Dixit R; Kofoed RH; Miloska K; Park E; Raeisossadati R; Markham-Coultes K; David LA; Rijal H; Zhao J; Lynch M; Hynynen K; Aubert I; Schuurmans C
    Theranostics; 2020; 10(7):2982-2999. PubMed ID: 32194850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.